These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 9661069)
21. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone. Alexandersen P; Peris P; GuaƱabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177 [TBL] [Abstract][Full Text] [Related]
22. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. Naot D; Bava U; Matthews B; Callon KE; Gamble GD; Black M; Song S; Pitto RP; Cundy T; Cornish J; Reid IR J Bone Miner Res; 2007 Feb; 22(2):298-309. PubMed ID: 17129176 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic progress--review VII. The medical treatment of Paget's disease. Sheppard MC J Clin Hosp Pharm; 1983 Mar; 8(1):35-44. PubMed ID: 6221033 [TBL] [Abstract][Full Text] [Related]
24. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment. Polyzos SA; Anastasilakis AD; Makras P; Terpos E Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962 [TBL] [Abstract][Full Text] [Related]
26. Diagnosis and treatment of Paget's disease of bone. Schneider D; Hofmann MT; Peterson JA Am Fam Physician; 2002 May; 65(10):2069-72. PubMed ID: 12046775 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological therapy of Paget's and other metabolic bone diseases. Hosking D Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763 [TBL] [Abstract][Full Text] [Related]
29. Analysis of environmental factors in familial versus sporadic Paget's disease of bone--the New England Registry for Paget's Disease of Bone. Seton M; Choi HK; Hansen MF; Sebaldt RJ; Cooper C J Bone Miner Res; 2003 Aug; 18(8):1519-24. PubMed ID: 12929942 [TBL] [Abstract][Full Text] [Related]
30. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy. Pirih FQ; Zablotsky M; Cordell K; McCauley LK J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656 [TBL] [Abstract][Full Text] [Related]
31. [Disorder of bone quality in Paget's disease]. Tsurukami H Clin Calcium; 2005 Jun; 15(6):1000-6. PubMed ID: 15930714 [TBL] [Abstract][Full Text] [Related]
37. Osteosarcoma in Paget's disease of bone. Hansen MF; Seton M; Merchant A J Bone Miner Res; 2006 Dec; 21 Suppl 2():P58-63. PubMed ID: 17229010 [TBL] [Abstract][Full Text] [Related]
38. Paget's disease of bone: clinical, pathogenetic and therapeutic aspects. Papapoulos SE Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):117-43. PubMed ID: 9222489 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of drugs for Paget's disease of bone. Reginster JY; Lecart MP Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423 [TBL] [Abstract][Full Text] [Related]
40. Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. Haslam SI; Van Hul W; Morales-Piga A; Balemans W; San-Millan JL; Nakatsuka K; Willems P; Haites NE; Ralston SH J Bone Miner Res; 1998 Jun; 13(6):911-7. PubMed ID: 9626621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]